Lunai Bioworks (LNAI) Operating Income (2011 - 2026)
Lunai Bioworks (LNAI) posted quarterly Operating Income of -$1.5 million for Q1 2026, up 64.51% year-over-year from -$897974.7 in Q1 2025, and up 18.98% quarter-over-quarter from -$1.8 million in Q4 2025.
Lunai Bioworks (LNAI) Operating Income (2011 - 2026) Analysis & Trends
Lunai Bioworks' Operating Income history runs 15 years deep, the most recent figure standing at -$1.5 million for Q1 2026.
- In Q1 2026, Operating Income rose 64.51% year-over-year to -$1.5 million; the TTM figure through Mar 2026 stood at -$133.5 million (down 68.7% YoY), while the FY2025 annual figure was -$189.0 million, down 131.46% from the prior year.
- Operating Income for Q1 2026 stood at -$1.5 million, up from -$1.8 million in the prior quarter.
- The five-year high for Operating Income was -$1.5 million in Q1 2026, with the low at -$126.9 million in Q2 2025.
- The 5-year median for Operating Income is -$4.5 million (2024), against an average of -$24.6 million.
- The sharpest annual moves came in 2024 and 2025: Operating Income plunged 1164.47% in 2024, then surged 93.8% in 2025.
- Lunai Bioworks' Operating Income stood at -$4.4 million in 2022, then advanced by 2.24% to -$4.3 million in 2023, then declined by 6.47% to -$4.5 million in 2024, then soared by 59.89% to -$1.8 million in 2025, then climbed by 18.98% to -$1.5 million in 2026.
- Business Quant data shows LNAI's Operating Income at -$1.5 million in Q1 2026, -$1.8 million in Q4 2025, and -$3.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 231.44 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.55 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 133.12 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -375.75 Mn |
| 10 | Lunai Bioworks | 6.87 Mn | 3.72 Mn | 20,942.00 | -1.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.48 Mn |
| Dec 31, 2025 | -1.82 Mn |
| Sep 30, 2025 | -3.31 Mn |
| Jun 30, 2025 | -126.92 Mn |
| Mar 31, 2025 | -4.16 Mn |
| Dec 31, 2024 | -4.55 Mn |
| Sep 30, 2024 | -53.34 Mn |
| Jun 30, 2024 | -17.10 Mn |
| Mar 31, 2024 | -51.38 Mn |
| Dec 31, 2023 | -4.27 Mn |
| Sep 30, 2023 | -8.88 Mn |
| Jun 30, 2023 | -22.93 Mn |
| Mar 31, 2023 | -4.06 Mn |
| Dec 31, 2022 | -4.37 Mn |
| Sep 30, 2022 | -7.19 Mn |
| Jun 30, 2022 | -98.21 Mn |
| Mar 31, 2022 | -4.03 Mn |
| Dec 31, 2021 | -6.33 Mn |
| Sep 30, 2021 | -7.50 Mn |
| Jun 30, 2021 | -14.18 Mn |